Ischemic optic neuropathy as the first manifestation of elevated cholesterol levels in young patients

Ophthalmology

Volumn 110, Issue 5, 2003, Pages 1041-1046

  Deramo, Vincent A ^a,d,e   Sergott, Robert C ^a   Augsburger, James J ^b   Foroozan, Rod ^a   Savino, Peter J ^a   Leone, Anthony ^c  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c University of Medicine   (United States)

^d Long Island Vitreoretinal Consultants   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; LIPID;

ARTICLE; CENTRAL NERVOUS SYSTEM; CHOLESTEROL BLOOD LEVEL; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMYELINATION; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC OPTIC NEUROPATHY; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NONARTERITIC ISCHEMIC OPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE DISEASE; PRIORITY JOURNAL; VISUAL IMPAIRMENT;

EID: 0037542771     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(03)00079-4     Document Type: Article

References (45)

1. Boghen DR, Glaser JS. Ischaemic optic neuropathy. The clinical profile and natural history. Brain 1975;98:689-708.
2. Repka MX, Savino PJ, Schatz NJ, Sergott RC. Clinical profile and long-term implications of anterior ischemic optic neuropathy. Am J Ophthalmol 1983;96:478-83.
3. Beri M, Klugman MR, Kohler JA, Hayreh SS. Anterior ischemic optic neuropathy. VII. Incidence of bilaterality and various influencing factors. Ophthalmology 1987;94:1020-8.
4. Guyer DR, Miller NR, Auer CL, Fine SL. The risk of cerebrovascular and cardiovascular disease in patients with anterior ischemic optic neuropathy. Arch Ophthalmol 1985;103: 1136-42.
5. Giuffre G. Hematological risk factors for anterior ischemic optic neuropathy. Neuroophthalmology 1990;10:197-203.
6. Katz B, Spencer WH. Hyperopia as a risk factor for nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1993;116:754-8.
7. Hayreh SS, Joos KM, Podhajsky PA, Long CR. Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1994;118:766-80.
8. Chung SM, Gay CA, McCrary JA 3rd. Nonarteritic ischemic optic neuropathy. The impact of tobacco use. Ophthalmology 1994;101:779-82.
9. Talks SJ, Chong NH, Gibson JM, Dodson PM. Fibrinogen, cholesterol and smoking as risk factors for non-arteritic anterior ischaemic optic neuropathy. Eye 1995;9:85-8.
10. Jacobson DM, Vierkant RA, Belongia EA. Nonarteritic anterior ischemic optic neuropathy. A case-control study of potential risk factors. Arch Ophthalmol 1997;115:1403-7.
11. Salomon O, Huna-Baron R, Kurtz S, et al. Analysis of prothrombotic and vascular risk factors in patients with nonarteritic anterior ischemic optic neuropathy. Ophthalmology 1999;106:739-42.
12. Ellenberger C Jr. Ischemic optic neuropathy as a possible early complication of vascular hypertension. Am J Ophthalmol 1979;88:1045-51.
13. Beck RW, Savino PJ, Repka MX, et al. Optic disc structure in anterior ischemic optic neuropathy. Ophthalmology 1984;91: 1334-7.
14. Doro S, Lessell S. Cup-disc ratio and ischemic optic neuropathy. Arch Ophthalmol 1985;103:1143-4.
15. Beck RW, Servais GE, Hayreh SS. Anterior ischemic optic neuropathy. IX. Cup-to-disc ratio and its role in pathogenesis. Ophthalmology 1987;94:1503-8.
16. Hayreh SS, Zimmerman MB, Podhajsky P, Alward WL. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol 1994;117:603-24.
17. Chisholm IA. Optic neuropathy of recurrent blood loss. Br J Ophthalmol 1969;53:289-95.
18. Hayreh SS. Anterior ischemic optic neuropathy. VIII. Clinical features and pathogenesis of post-hemorrhagic amaurosis. Ophthalmology 1987;94:1488-502.
19. Michaels DD, Zugsmith GS. Optic neuropathy following cataract extraction. Ann Ophthalmol 1973;5:303-6.
20. Hayreh SS. Anterior ischemic optic neuropathy. IV. Occurrence after cataract extraction. Arch Ophthalmol 1980;98: 1410-6.
21. Shapira OM, Kimmel WA, Lindsey PS, Shahian DM. Anterior ischemic optic neuropathy after open heart operations. Ann Thorac Surg 1996;61:660-6.
22. Worrall BB, Moazami G, Odel JG, Behrens MM. Anterior ischemic optic neuropathy and activated protein C resistance. A case report and review of the literature. J Neuroophthalmol 1997;17:162-5.
23. Kawasaki A, Purvin VA, Burgett RA. Hyperhomocysteinaemia in young patients with non-arteritic anterior ischaemic optic neuropathy. Br J Ophthalmol 1999;83:1287-90.
24. Acheson JF, Sanders MD. Coagulation abnormalities in ischaemic optic neuropathy. Eye 1994;8:89-92.
25. Togashi M, Numata K, Yamamoto S, Hayasaka S. Anterior ischemic optic neuropathy in a patient with positive antinuclear antibody and lupus anticoagulant findings. Ophthalmologica 1996;210:132-5.
26. Fry CL, Carter JE, Kanter MC, et al. Anterior ischemic optic neuropathy is not associated with carotid artery atherosclerosis. Stroke 1993;24:539-42.
27. Muller M, Wessel K, Mehdorn E, et al. Carotid artery disease in vascular ocular syndromes. J Clin Neuroophthalmol 1993; 13:175-80.
28. Hattenhauer MG, Leavitt JA, Hodge DO, et al. Incidence of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1997;123:103-7.
29. Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial. Arch Ophthalmol 1996;114:1366-74.
30. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Arch Intern Med 1988;148:36-69.
31. Serum cholesterol levels among persons 20 years of age and over, according to sex, age, race, and Hispanic origin. United States, 1960-62, 1971-74, 1976-80, and 1988-94. In: Health, United States, 1996-97. Hyattsville, MD: National Center for Health Statistics 1997;191. DHHS Publication PHS 97-1232.
32. Rizzo JF 3rd, Lessell S. Optic neuritis and ischemic optic neuropathy. Overlapping clinical profiles. Arch Ophthalmol 1991;109:1668-72.
33. Enos WF, Holmes RH, Beyer J. Coronary disease among United States soldiers killed in action in Korea Preliminary report. JAMA 1953;152:1090-3.
34. Enos WF, Holmes RH, Beyer J. Landmark article, July 18, 1953: Coronary disease among United States soldiers killed in action in Korea. Preliminary report. JAMA 1986;256:2859-62.
35. Berenson GS, Srinivasan SR, Bao W, et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998;338:1650-6.
36. Strong JP, Malcom GT, McMahan CA, et al. Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA 1999;281: 727-35.
37. Rossouw JE. Lipid-lowering interventions in angiographic trials. Am J Cardiol 1995;76:86C-92C.
38. Brown G, Albers JJ, Fisher LD, et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 1990;323:1289-98.
39. Blankenhorn DH, Azen SP, Kramsch DM, et al. Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS). The MARS Research Group. Ann Intern Med 1993;119:969-76.
40. Kane JP, Malloy MJ, Ports TA, et al. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. JAMA 1990;264:3007-12.
41. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.
42. The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 1984; 251:365-74.
43. Gilligan DM, Guetta V, Panza JA, et al. Selective loss of microvascular endothelial function in human hypercholesterolemia. Circulation 1994;90:35-41.
44. Ito A, Tsao PS, Adimoolam S, et al. Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation 1999;99:3092-5.
45. Beck RW, Hayreh SS, Podhajsky PA, et al. Aspirin therapy in nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1997;123:212-7.